Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

258
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
258
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

195
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
195

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and Risk Factors of Hypernatremic Dehydration in Exclusively Breastfed Neonates: A Systematic Review and Meta-Analysis.

Journal of clinical medicine·2026
Same author

Current Evidence on the Relationship Between Perioperative Hypothermia and Surgical Site Infection: A Scoping Review.

Journal of clinical medicine·2026
Same author

Risk Factors Associated with Anterior Cruciate Ligament Injuries in Athletes During Physical Activity According to Sex: A Scoping Review.

Sports (Basel, Switzerland)·2026
Same author

Impact of Preoperative Nutritional Status on Postoperative Outcomes of Total Hip and Knee Arthroplasty: A Scoping Review.

Medicina (Kaunas, Lithuania)·2026
Same author

Hemodynamic and Thrombotic Vulnerability in Pulmonary Arterial Hypertension at High Altitude: Multivariable Predictors of Mortality.

Medicina (Kaunas, Lithuania)·2026
Same author

Validation of SpO<sub>2</sub>/FiO<sub>2</sub> as a Non-Invasive Surrogate of PaO<sub>2</sub>/FiO<sub>2</sub> in Mechanically Ventilated COVID-19 Patients at High Altitude.

Advances in respiratory medicine·2026

Related Experiment Video

Updated: Jun 23, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

10.9K

Curve-Modelling and Machine Learning for a Better COPD Diagnosis.

Adriana Maldonado-Franco1, Luis F Giraldo-Cadavid2,3, Eduardo Tuta-Quintero2

  • 1School of Engineering, Universidad de La Sabana, Chía, Colombia.

International Journal of Chronic Obstructive Pulmonary Disease
|June 19, 2024
PubMed
Summary

Artificial Neural Networks can aid in diagnosing Chronic Obstructive Pulmonary Disease (COPD). Using spirometry data, this AI model achieved 92.9% accuracy, outperforming current diagnostic standards.

Keywords:
COPDaccuracyartificial neural networksdiagnosismachine learning

More Related Videos

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

4.3K
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

13.2K

Related Experiment Videos

Last Updated: Jun 23, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

10.9K
Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

4.3K
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

13.2K

Area of Science:

  • Medical Artificial Intelligence
  • Pulmonary Medicine
  • Biomedical Engineering

Background:

  • Artificial intelligence (AI) excels at recognizing complex patterns, showing promise for diagnosing Chronic Obstructive Pulmonary Disease (COPD).
  • Accurate and early COPD diagnosis is crucial for effective patient management and treatment.

Purpose of the Study:

  • To develop and evaluate an AI-based system for diagnosing COPD using spirometry data.
  • To assess the performance of neural networks in classifying COPD patients.

Main Methods:

  • An observational, analytical, single-center study involving 695 patients undergoing spirometry.
  • Quadratic polynomials modeled the spirometric curve segment from peak expiratory flow to forced vital capacity.
  • Coefficients from these models trained and tested three neural networks (pre-bronchodilator, post-bronchodilator, and combined data).

Main Results:

  • The best-performing neural network utilized post-bronchodilator coefficients, achieving 92.9% accuracy, 88.2% sensitivity, and 94.3% specificity.
  • This AI system demonstrated superior performance compared to the gold standard, particularly in specificity and negative predictive value.
  • The COPD group was significantly older than the non-COPD group.

Conclusions:

  • Artificial Neural Networks, trained on polynomial coefficients from spirometry, show potential in emulating clinical COPD diagnosis.
  • This AI approach can serve as a valuable tool in primary care for early COPD detection.
  • Further development could enhance AI's role in respiratory disease diagnostics.